BioImagene

Medical Devices & EquipmentSeries DSunnyvale, US

Latest round

Series D

Last raised

Aug 2008

Total raised

$25M

Investors

8

About BioImagene

Founded in 20023 and based in California, US, BioImagene Inc. operates as a medical equipment manufacturer that provides digital pathology solutions for clinical diagnostics and drug discovery applications. It develops and distributes integrated hardware and software systems to acquire, view, share, manage, archive, and analyze tissue images in pathology laboratories.

Who invested in BioImagene

8 investors across 3 rounds

See all investors in BioImagene

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series D

    Aug 8, 2008

    Amount

    $17M

    Investors

    Locked

  2. Series C

    Mar 29, 2006

    Amount

    $5M

    Investors

    Locked

  3. Series B

    Oct 13, 2004

    Amount

    $3M

    Investors

    Locked

Questions about BioImagene

Who invested in BioImagene?

BioImagene has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has BioImagene raised?

BioImagene has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did BioImagene last raise money?

BioImagene's most recent round on record is a Series D, in Aug 2008.

What does BioImagene do?

Founded in 20023 and based in California, US, BioImagene Inc.

Where is BioImagene headquartered?

BioImagene is headquartered in Sunnyvale, US.

Which VCs invest in companies like BioImagene?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at BioImagene's stage. Their profiles are linked below.

Raising like BioImagene? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.